SharkNinja Q3 Sales Up 21.2%, Raises FY2026 Outlook; Valuation and Control Concerns Remain

What happened

SharkNinja reported Q3 2026 sales growth of 21.2% year over year, with strength across domestic and international markets and particular demand in cooking, beverage, and beauty categories. Management raised its full-year 2026 outlook on the back of the beat, signaling continued momentum beyond the already strong first half that saw 22.2% sales growth in Q2. The company had previously guided to 16-17% sales growth and adjusted EPS of $6.45-$6.55, but the new guidance implies higher expectations, likely reflecting the $247.1 million tariff refund recognized in Q3 and continued share gains. Despite the upbeat top line, gross margin remained pressured by tariffs and retailer activations, and the company still faces unresolved material weaknesses in internal controls. The stock's valuation was already demanding at $180.30 (36x P/E), and the raised guidance may push it further into premium territory unless margin recovery and control remediation become visible.

Implication

The raised guidance and strong Q3 sales validate SharkNinja's innovation-led growth story, but they do not resolve the key concerns that capped our rating. Gross margin remains below prior-year levels due to tariffs and retailer funding, and the company has yet to demonstrate that the tariff refund will translate into sustainable margin expansion rather than being reinvested. The stock's valuation at 36x P/E already prices in continued high growth, leaving little room for error if holiday sell-through or international expansion disappoints. We maintain our WAIT rating, but the risk/reward has deteriorated if the stock has moved above $195; a pullback to around $155 would offer a more attractive entry. Until management shows clean ICFR remediation and post-refund margin improvement, we prefer to stand aside.

Thesis delta

No material change to our WAIT thesis: the Q3 beat and raised guidance confirm the company's growth algorithm but do not address the margin and governance overhangs that keep us cautious. The stock's valuation may now be even more stretched, making the entry price even more critical. We would only consider upgrading if post-refund gross margin expands and control weaknesses are fully remediated.